What are the latest figures on the biochemistry analyzers market’s size and projected CAGR?
The biochemistry analyzers market size has grown strongly in recent years. It will grow from $4.5 billion in 2024 to $4.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising healthcare expenditure, focus on early disease detection, increased research and development, rising awareness of preventive healthcare, and government health initiatives.
The biochemistry analyzers market size is expected to see strong growth in the next few years. It will grow to $6.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increased automation in laboratories, advancements in molecular diagnostics, expansion of biotech, development of point-of-care testing, and growth in personalized medicine. Major trends in the forecast period include integration with artificial intelligence, miniaturization and portability, enhanced multimodal capabilities, sustainability and eco-friendly products, and expansion of reagent and consumable markets.
Get Your Free Sample of The Global Biochemistry Analyzers Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20511&type=smp
Which Market drivers have played a significant role in driving the biochemistry analyzers market?
The increasing number of chronic disorders is expected to propel the growth of the biochemistry analyzers market going forward. Chronic disorders refer to long-term health conditions that persist over time and often require continuous management and care. The increasing number of chronic disorders is primarily due to aging populations, lifestyle changes, and rising risk factors such as poor diet, physical inactivity, and pollution. Biochemistry analyzers are used in chronic disorders to measure and monitor biomarkers for diagnosis, disease progression, and treatment effectiveness. For instance, in August 2022, according to a report published by the American College of Cardiology, a US-based non-profit medical association, in the United States, it is projected that all four major cardiovascular risk factors will increase from 2025 to 2060. Diabetes is expected to see the largest percentage rise, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Therefore, the increasing number of chronic disorders is driving the growth of the biochemistry analyzers market.
What are the key segments within the biochemistry analyzers market?
The biochemistry analyzers market covered in this report is segmented –
1) By Product Type: Semi-automated Biochemistry Analyzer, Fully Automated Biochemistry Analyzer
2) By Modality: Bench-top, Floor Standing
3) By Application: Clinical Diagnostics, Bioreactor Byproduct Detection, Drug Development Applications, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations
Subsegments:
1) By Semi-Automated Biochemistry Analyzer: Benchtop Semi-Automated Analyzers, Portable Semi-Automated Analyzers, Miniaturized Semi-Automated Analyzers
2) By Fully Automated Biochemistry Analyzer: High-Throughput Fully Automated Analyzers, Integrated Fully Automated Analyzers, Point-of-Care Fully Automated Analyzers
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/biochemistry-analyzers-global-market-report
Which key players are shaping the biochemistry analyzers market?
Major companies operating in the biochemistry analyzers market are Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Medline Industries LP, Tosoh Corporation, Agilent Technologies Inc, bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Qiagen NV, Werfen Group SA, DiaSorin SpA, Bio-Techne Corporation, Meril Life Sciences Private Limited, Randox Laboratories Ltd, Getein Biotech Inc, Aesku Diagnostics GmbH & Co KG, Carolina Liquid Chemistries Corporation, Arlington Scientific Inc, Chengdu Seamaty Technology Co Ltd, Hipro Biotechnology Co Ltd.
Which transformative trends will shape the biochemistry analyzers market landscape?
Major companies operating in the biochemistry analyzers market are focused on developing innovative solutions, such as the chemistry analyzer, to empower medium-volume laboratories with increased productivity, efficiency, and reliability. A chemistry analyzer is a diagnostic device used to measure and analyze chemical components in biological samples, such as blood or urine, to assess health and diagnose diseases. For instance, in May 2022, Mindray Bio-Medical Electronics Co., Ltd., a China-based medical devices company, launched the BS-600M Chemistry Analyzer, a device designed to enhance the productivity and efficiency of medium-volume laboratories. This analyzer is notable for its compact footprint of just 1.2 square meters while achieving a throughput of 600 tests per hour, which can be increased to 800 tests per hour when using the integrated Ion Selective Electrode (ISE) module. This high throughput per square meter makes it a leading option for labs looking to maximize space and efficiency.
How do regional factors impact the biochemistry analyzers market, and which region is the largest contributor?
North America was the largest region in the biochemistry analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochemistry analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Biochemistry Analyzers Market Report 2025 Offer?
The biochemistry analyzers market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Biochemistry analyzers are laboratory devices used to measure the concentration of various biochemical substances in biological samples, such as blood, urine, serum, plasma, and cerebrospinal fluid. These devices play a crucial role in clinical diagnostics by helping to analyze chemical reactions and properties related to metabolism, organ function, and the presence of specific diseases.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20511
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
